GENE ONLINE|News &
Opinion
Blog

Moderna
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Moderna’s mRNA Flu Vaccine Development Slow Going as Data Rolls In
2023-04-11
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
A New Phase in Drug Development: Programming the Genome
2023-03-02
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
FDA Approves Both Moderna’s and Pfizer/BioNTech’s Omicron Bivalent Vaccines in One Day
2022-08-31
Moderna Wins the First Regulatory Approval for an Omicron Bivalent Vaccine
2022-08-30
Moderna’s Lawsuit Against Pfizer/BioNTech: What Does This Mean for Their Vaccine’s future?
2022-08-26
Moderna Follows Pfizer With Their Own Omicron BA.4/BA.5 Application to the FDA
2022-08-24
European Commision Purchases an additional 15 million Moderna Bivalent COVID-19 Vaccines
2022-08-09
1 2 3 5
LATEST
From Sweet to Risky: The Alarming Findings on Sucralose’s Genotoxicity
2023-06-07
GHG Emissions as a ESG Metric
2023-06-07
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
The Emergence of General AI for Medicine: Medical Applications of ChatGPT
2023-06-06
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
2023 International Healthcare Week: Showcasing Emerging Competencies of Hong Kong’s Biomedical Industry
2023-06-05
Scroll to Top